Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Impaired Albumin Uptake and Processing Promote Albuminuria in OVE26 Diabetic Mice.

Long YS, Zheng S, Kralik PM, Benz FW, Epstein PN.

J Diabetes Res. 2016;2016:8749417. Epub 2016 Oct 16.

2.

Diabetes Induced Changes in Podocyte Morphology and Gene Expression Evaluated Using GFP Transgenic Podocytes.

Xu J, Zheng S, Kralik PM, Krishnan L, Huang H, Hoying JB, Cai L, Carlson EC, Tan Y, Epstein PN.

Int J Biol Sci. 2016 Jan 1;12(2):210-8. doi: 10.7150/ijbs.13057. eCollection 2016.

3.

Inflammatory gene expression in OVE26 diabetic kidney during the development of nephropathy.

Yang L, Brozovic S, Xu J, Long Y, Kralik PM, Waigel S, Zacharias W, Zheng S, Epstein PN.

Nephron Exp Nephrol. 2011;119(1):e8-20. doi: 10.1159/000324407. Epub 2011 May 23.

PMID:
21606656
4.

Diabetic albuminuria is due to a small fraction of nephrons distinguished by albumin-stained tubules and glomerular adhesions.

Kralik PM, Long Y, Song Y, Yang L, Wei H, Coventry S, Zheng S, Epstein PN.

Am J Pathol. 2009 Aug;175(2):500-9. doi: 10.2353/ajpath.2009.080939. Epub 2009 Jul 2.

5.

Podocyte-specific overexpression of the antioxidant metallothionein reduces diabetic nephropathy.

Zheng S, Carlson EC, Yang L, Kralik PM, Huang Y, Epstein PN.

J Am Soc Nephrol. 2008 Nov;19(11):2077-85. doi: 10.1681/ASN.2007080967. Epub 2008 Jul 16.

6.

Causes and characteristics of diabetic cardiomyopathy.

Wang J, Song Y, Wang Q, Kralik PM, Epstein PN.

Rev Diabet Stud. 2006 Fall;3(3):108-17. Epub 2006 Nov 10.

7.

Cardiomyocyte dysfunction in models of type 1 and type 2 diabetes.

Kralik PM, Ye G, Metreveli NS, Shem X, Epstein PN.

Cardiovasc Toxicol. 2005;5(3):285-92. Erratum in: Cardiovasc Toxicol. 2006;6(1):79. Kralik, Patricia M [added]; Donthi, Rajakumar V [removed]; Shem, Xia [added].

PMID:
16244373
8.

Development of late-stage diabetic nephropathy in OVE26 diabetic mice.

Zheng S, Noonan WT, Metreveli NS, Coventry S, Kralik PM, Carlson EC, Epstein PN.

Diabetes. 2004 Dec;53(12):3248-57.

9.

Elevated hexokinase increases cardiac glycolysis in transgenic mice.

Liang Q, Donthi RV, Kralik PM, Epstein PN.

Cardiovasc Res. 2002 Feb 1;53(2):423-30.

PMID:
11827693
10.

Overexpression of metallothionein reduces diabetic cardiomyopathy.

Liang Q, Carlson EC, Donthi RV, Kralik PM, Shen X, Epstein PN.

Diabetes. 2002 Jan;51(1):174-81.

11.

Catalase transfection decreases hydrogen peroxide toxicity in a pancreatic beta cell line.

Kralik PM, Xu B, Epstein PN.

Endocr Res. 1998 Feb;24(1):79-87.

PMID:
9553756
12.

Kinetic evaluation of platelet monoamine oxidase following relaxation in chronic anxiety.

Kralik PM, Ho BT, Mathew RJ, Claghorn JL.

Acta Psychiatr Scand. 1983 May;67(5):307-14.

PMID:
6346805
13.

Effects of adrenaline administration on platelet MAO of anxious and normal subjects.

Kralik PM, Ho BT, Mathew RJ, Taylor DL, Weinman ML.

Neuropsychobiology. 1982;8(4):205-9. No abstract available.

PMID:
7133369
14.

Effect of delta-THC on ethanol withdrawal in mice.

Kralik PM, Ho BT, Matthews HR.

Experientia. 1976 Jun 15;32(6):723-5.

PMID:
985757
15.

Inhibitors of monoamine oxidase. VI. Effects of substitution on inhibitory activity of 6(or 8)-substituted beta-carbolines.

Ho BT, Li KC, Walker KE, Tansey LW, Kralik PM, McIsaac WM.

J Pharm Sci. 1970 Oct;59(10):1445-8. No abstract available.

PMID:
5471952
16.

Distribution of tritiated-1 delta 9tetrahydrocannabinol in rat tissues after inhalation.

Ho BT, Fritchie GE, Kralik PM, Englert LF, McIsaac WM, Idänpään-Heikkilä J.

J Pharm Pharmacol. 1970 Jul;22(7):538-9. No abstract available.

PMID:
4395492
17.

Biological activities of some 5-substituted N,N-dimethyltryptamines, alpha-methyltryptamines, and gramines.

Ho BT, McIsaac MW, An R, Harris RT, Walker KE, Kralik PM, Airaksinen MM.

Psychopharmacologia. 1970;16(5):385-94. No abstract available.

PMID:
5435874
18.

Inhibitors of monoamine oxidase. V. Effect of substitution on the transport of tetrahydro-beta-carboline analogs to mouse brain.

Ho BT, Fritchie GE, Kralik PM, Tansey LW, Walker KE, McIsaac WM.

J Pharm Sci. 1969 Nov;58(11):1423-5. No abstract available.

PMID:
5349767
19.

Hydroxyindole-O-methyltransferase. II. Inhibitory activities of some N-acyltryptamines.

Ho BT, McIsaac WM, Tansey LW, Kralik PM.

J Pharm Sci. 1968 Nov;57(11):1998-2000. No abstract available.

PMID:
5725938

Supplemental Content

Loading ...
Support Center